Molecular MRI of Early Thrombus Formation Using a Bimodal α2-Antiplasmin–Based Contrast Agent | Zendy

Robbert-Jan J.H.M. Miserus | Zendy; M. Verónica Herías | Zendy; Lenneke Prinzen | Zendy; Marc B. I. Lobbes | Zendy; RobertJan van Suylen | Zendy; Anouk Dirksen | Zendy; Tilman M. Hackeng | Zendy; Johan W. M. Heemskerk | Zendy; Jos M. A. van Engelshoven | Zendy; Mat J.A.P. Daemen | Zendy; Marc A. M. J. van Zandvoort | Zendy; Sylvia Heeneman | Zendy; M. Eline Kooi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Molecular MRI of Early Thrombus Formation Using a Bimodal α2-Antiplasmin–Based Contrast Agent

Author(s) -

Robbert-Jan J.H.M. Miserus,

M. Verónica Herías,

Lenneke Prinzen,

Marc B. I. Lobbes,

RobertJan van Suylen,

Anouk Dirksen,

Tilman M. Hackeng,

Johan W. M. Heemskerk,

Jos M. A. van Engelshoven,

Mat J.A.P. Daemen,

Marc A. M. J. van Zandvoort,

Sylvia Heeneman,

M. Eline Kooi

Publication year - 2009

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2009.03.015

Subject(s) - thrombus , in vivo , chemistry , fibrin , magnetic resonance imaging , in vitro , pathology , nuclear magnetic resonance , microbiology and biotechnology , medicine , biochemistry , biology , immunology , radiology , physics

We aimed to investigate whether early thrombus formation can be visualized with in vivo magnetic resonance imaging (MRI) by the use of a novel bimodal alpha(2)-antiplasmin-based contrast agent (CA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research